Scarica l'app Stockscreener
1.13
6.61%
-0.08
Pre-mercato:
1.16
0.03
+2.65%
Precedente Chiudi:
$1.21
Aprire:
$1.23
Volume 24 ore:
142.74K
Relative Volume:
0.63
Capitalizzazione di mercato:
$88.56M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-15.04%
1M Prestazione:
-36.87%
6M Prestazione:
+26.97%
1 anno Prestazione:
+14.14%
Intervallo 1D:
$1.13
$1.2703
Intervallo di 1 settimana:
$1.13
$1.36
Portata 52W:
$0.5506
$6.19
Citius Oncology Inc Stock (CTOR) Company Profile
Nome
Citius Oncology Inc
Settore
Telefono
(908) 967-6677
Indirizzo
11 COMMERCE DRIVE, CRANFORD
Confronta CTOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTOR
Citius Oncology Inc
|
1.13 | 101.05M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2024-11-27 | Iniziato | Maxim Group | Buy |
Citius Oncology Inc Borsa (CTOR) Ultime notizie
Is Citius Oncology Inc. stock attractive after correctionQuarterly Market Review & Fast Gaining Stock Reports - newser.com
Citius Oncology Inc.’s volatility index tracking explainedWeekly Stock Recap & Safe Investment Capital Preservation Plans - newser.com
Will Citius Oncology Inc. stock rally after Fed decisionsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Will Citius Oncology Inc. stock keep outperforming rivals2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - newser.com
Using Bollinger Bands to evaluate Citius Oncology Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - newser.com
How Citius Oncology Inc. stock compares to market leadersPortfolio Growth Summary & Weekly Breakout Watchlists - newser.com
Is Citius Oncology Inc. stock supported by innovation pipeline2025 Price Momentum & Short-Term Trading Alerts - newser.com
Will Citius Oncology Inc. stock deliver strong dividend growth2025 Volatility Report & Community Shared Stock Ideas - newser.com
How Citius Oncology Inc. stock reacts to oil pricesWeekly Volume Report & Weekly High Conviction Ideas - newser.com
What the charts say about Citius Oncology Inc. today2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Why Citius Oncology Inc. stock is a value investor pickJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
What data driven models say about Citius Oncology Inc.’s futureJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
News impact scoring models applied to Citius Oncology Inc.Earnings Overview Summary & AI Forecast Swing Trade Picks - newser.com
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences - Lelezard
What high frequency data says about Citius Oncology Inc.July 2025 Snapshot & Low Drawdown Momentum Trade Ideas - newser.com
Citius Oncology Inc Azioni (CTOR) Dati Finanziari
Non sono disponibili dati finanziari per Citius Oncology Inc (CTOR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
6.17%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):